Your search for Warfarin returned 256 results

Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events

Findings may help with decision-making in this high-risk patient population.

Although more research is needed, data suggest that the cardioprotective effect of direct oral anticoagulants may extend to patients with advanced CKD.

The patients, a 71-year-old male and a 62 year-old-male, both on long-term warfarin therapy, presented to the emergency department with symptoms of COVID-19.

No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants

Morning or evening administration makes no difference on time outside target INR range.

Noninferiority not found compared with standard-intensity prophylaxis with hip or knee arthroplasty

The patient in this case had been well-controlled on warfarin therapy for over 5 years following mitral valve replacement.

Results from a new real-world study evaluating rivaroxaban (Xarelto; Janssen), a factor Xa inhibitor, in morbidly obese patients were recently published in Thrombosis Research. The retrospective cohort study analyzed data from 2 US claims databases (Truven MarketScan Commercial Claims and Encounters database and MarketScan Medicare Supplemental database) to evaluate the clinical and health/economic outcomes of…

“The elevation in INR can be explained by the inhibition of CYP2C9 by cannabis use causing decreased metabolism of warfarin,” the authors explained.